Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Neuroendocrine Carcinoma of the Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Not applicableTemporarily pausedNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Not applicableLooking for participantsNCT04693377
What this trial is testing

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the Bone+15 more
M.D. Anderson Cancer Center 40
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Not applicableAvailableNCT04853602
What this trial is testing

IFx-Hu2.0 Expanded Access Program

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT02318771
What this trial is testing

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Next Page